Hypertrophic Cardiomyopathy (HCM) Patient Opportunity
Hypertrophic cardiomyopathy (HCM) patients can register and participate in a virtual drug development meeting. Comments and questions they will be able to ask throughout the meeting will be used by the FDA to hear what HCM patients go through.
Patient Focused Drug Development Meeting
Friday, June 26th from 9:45 AM EDT to 2:30 PM EDT
The HCMA will be holding a fully virtual PFDD Patient-Focused Drug Development Meeting
Please put down "AHA-Patient", "AHA-Caregiver" or "AHA-Family Member" for your Organization Name, if you do not have an organization.
Email SupportNetwork@heart.org if you have any questions!